Dr. Rizzo studies various aspects of mental and physical health, with a keen focus on conditions like workplace victimization, severe malaria, and different types of cancer. For instance, he has explored how psychological abuse at work can lead to significant mental health challenges, such as increased anxiety and depression among affected workers. Additionally, he researches advanced cancer treatments, including how new imaging techniques can improve survival predictions for prostate cancer patients and how genetic factors influence kidney cancer treatment responses. His work also touches on sustainable practices, such as how green roofs can use greywater to conserve water.
Key findings
In a study on workplace victimization, anxiety levels were recorded at an alarming average of 65.06 points, indicating severe emotional distress among workers.
In patients with severe malaria, those diagnosed had D-dimer levels averaging 10,943 µg/L compared to 2,245 µg/L in milder cases, suggesting higher levels indicate more severe disease.
In prostate cancer patients undergoing specific therapy, the appearance of new tumors increased the risk of death by about 2.78 times and shortened the period without worsening PSA levels by 4.72 times.
For advanced urothelial carcinoma, patients with lower performance status (ECOG-PS 2) had a median overall survival of 6.34 months, significantly shorter than those with higher performance statuses.
Liquid biopsy methods were shown to have the potential to improve detection of genetic changes in biliary tract cancers, enhancing treatment decision-making.
Frequently asked questions
Does Dr. Rizzo study workplace bullying?
Yes, he examines the psychological effects of workplace victimization and its impact on mental health.
What types of cancer treatments has Dr. Rizzo researched?
He has researched advanced cancer therapies such as lutetium-177 for prostate cancer and enfortumab vedotin for bladder cancer.
How does Dr. Rizzo's research help patients with severe malaria?
His findings on D-dimer levels may help doctors predict disease severity and improve treatment strategies.
Is Dr. Rizzo's work relevant for patients with kidney cancer?
Yes, his research provides insights into how sex differences can affect treatment responses in renal cell carcinoma.
What are green roofs, and how is Dr. Rizzo involved?
Dr. Rizzo studies how green roofs can effectively treat greywater, promoting sustainable urban water management practices.
Publications in plain English
Effect of Long-Term Contraception with Altrenogest in Dolphins ().
2026
Animals : an open access journal from MDPI
Cicirelli V, Carbonari A, Forte L, Carreca R, Canales R +3 more
Plain English This study looked at the effects of a contraceptive drug called Altrenogest on female dolphins at four zoological parks in Spain between 2020 and 2025. It found that the drug significantly lowered progesterone levels and increased estrogen levels, indicating it effectively prevents pregnancy but can also lead to health issues—four dolphins developed a serious uterine condition and three had ovarian cysts. Understanding these effects is important for managing dolphin populations in captivity and ensuring their health while using this contraceptive method.
Who this helps: This helps dolphin caretakers and veterinarians in managing female dolphins’ reproductive health.
Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative review.
2026
Frontiers in public health
Scaglione G, Mastroianni N, Rizzo A, Palomba E, Carcione D +5 more
Plain English This research paper explores how combining artificial intelligence (AI) with genome sequencing can improve our ability to identify and combat antimicrobial resistance (AMR), which threatens global health. The study highlights that AI can enhance diagnostic processes by analyzing genetic material to predict resistance and detect pathogens more quickly and accurately. This matters because it can lead to faster and more precise treatments, ultimately saving lives and better managing infections.
Who this helps: This benefits patients, healthcare providers, and public health officials.
Socioeconomic and cultural correlates of illicit alcohol consumption among patrons in Uganda: a mixed-methods approach.
2026
BMC public health
Niwagaba K, Rwakahangi SP, Tumwine M, Kakuba C, Matagi L +4 more
Plain English This study examined the use of illegal alcohol in Uganda, where over 6.5 million people drink it, impacting their health and the economy. Of 400 participants, 301 (75.2%) reported consuming illicit alcohol in the past week, with many being low-income, less-educated young men. Key factors influencing consumption included age, employment status, cost, and peer pressure, highlighting the need for targeted interventions to address these issues.
Who this helps: This benefits patients struggling with alcohol dependence and communities impacted by alcohol-related harm.
Shared occurrence ofspp. in dogs and their owners.
2026
One health (Amsterdam, Netherlands)
Miglianti M, Bezerra-Santos MA, Rizzo A, Pugliese N, Iatta R +3 more
Plain English This study looked at the presence of a type of yeast in both dogs and their owners to see if there was a connection between the two. It found that 68.5% of the dogs had the yeast, compared to 21.9% of the owners, and a relationship was noted where dogs with the yeast made it more likely for their owners to have it too. The study highlights the need for better testing methods for these infections, especially since the yeast can cause health issues, particularly for those with weakened immune systems.
Who this helps: This helps patients and veterinarians by raising awareness of potential infections that can be shared between pets and their owners.
Correction: Prevalence of illicit alcohol consumption and associated factors among adolescents in selected communities of Lusaka, Zambia.
2026
PloS one
Menda DM, Achoki T, Ntebeka BM, Zimba RK, Mulikita CM +7 more
Plain English This study looked at how many teenagers in certain neighborhoods of Lusaka, Zambia, drink alcohol illegally. The researchers found that a significant number—about 30% of the adolescents—reported consuming alcohol, with factors like peer influence and availability playing a big role. Understanding these patterns is important because it can help create better support and prevention strategies for young people.
Who this helps: This benefits parents, educators, and health professionals working with adolescents.
Unraveling mercury dynamics in shallow lakes: Evidence from a pristine oligotrophic lake in a natural mercury hotspot of the Patagonian Andes.
2026
Chemosphere
Fernandez Z, Soto Cárdenas C, Arcagni M, Rizzo A, Diéguez MC
Plain English This study investigated how mercury behaves in Lake Pire, a clear lake in the Patagonian Andes with no human pollution. Researchers found that mercury levels changed significantly with the seasons: during wet periods, mercury concentration was up to 82.42 nanograms per liter but rose to 365 nanograms per liter in deeper waters during dry months. Understanding how mercury moves and accumulates in this ecosystem is important because it can affect the entire food web, including fish that people may eat.
Who this helps: This helps patients, especially those concerned about mercury exposure from fish consumption.
Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps.
2026
Drug design, development and therapy
Erul E, Cifuentes-Canaval S, Santhosh A, Sokolović E, Della Mura M +3 more
Plain English This study examined the role of FGFR2 alterations in a type of bile duct cancer called intrahepatic cholangiocarcinoma (iCCA), finding that these changes are a key target for treatment. The researchers found that using FGFR inhibitors, which are drugs designed to block the FGFR2 protein, can be effective in patients with FGFR2 alterations, although they also noted some specific side effects. This research is important because it helps guide more personalized treatment options for patients with this rare cancer, ultimately aiming to improve outcomes.
Who this helps: Patients with intrahepatic cholangiocarcinoma.
Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
2026
Expert opinion on biological therapy
Di Marco L, Valerio F, Maculan Y, Medici B, Spallanzani A +4 more
Plain English This research looked at combining two immunotherapy drugs, nivolumab and ipilimumab, to treat advanced liver cancer, known as hepatocellular carcinoma (HCC). The results showed that this combination can significantly improve patient survival, making it a strong option for treatment, although there are some additional side effects to consider. For example, patients receiving this combination therapy showed better responses and longer survival compared to those taking traditional treatments.
Who this helps: This helps patients with advanced liver cancer and their doctors.
Optimized genetic tracers for viral mediated neuronal projection mapping.
2026
Cellular & molecular biology letters
Dulin JN, Ye L, Grider T, Rizzo A, Rosenzweig ES +7 more
Plain English This study focused on improving how scientists can trace nerve connections in the nervous system using a new type of fluorescent protein called COMET. The researchers found that COMET tracers outperformed traditional methods, allowing them to detect finer details of nerve pathways and observe regenerating nerves after spinal cord injuries. This advancement is important because it improves our ability to analyze nerve damage and healing, which can lead to better treatments for nerve-related issues.
Who this helps: This helps patients with spinal cord injuries and their doctors by providing better tools for understanding nerve repair.
Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors.
2026
Clinical cancer research : an official journal of the American Association for Cancer Research
Ricci AD, Rizzo A
Plain English This study looked at new treatment options for patients with brain tumors that started from rare cancers. The researchers found that a special combination of immune therapies improved responses in these patients, which is promising for their treatment. This matters because it opens up new possibilities for tackling difficult-to-treat brain metastases, potentially leading to better outcomes for patients.
Who this helps: This helps patients with rare tumors that have spread to the brain.
High rate of undiagnosed cases of fever among returning travelers from tropical areas tested for malaria: a single-center retrospective study.
2026
Travel medicine and infectious disease
Caronni S, Pieruzzi ME, Salari F, Behring AH, Rizzo A +11 more
Plain English This study looked at travelers returning to Italy from tropical areas who had fevers, to see how many of them were diagnosed with specific illnesses. Among 778 people studied, 57% (or 446 individuals) did not receive a specific diagnosis, although this number improved over time. The most common diagnosed illness was dengue fever, found in 95 cases, followed by malaria and pneumonia. Understanding the reasons behind these fevers is important for better diagnosis and treatment of returning travelers.
Who this helps: This helps patients returning from tropical areas and their doctors.
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?
2026
Frontiers in immunology
Cerbone L, Roviello G, Calabrò F, Taha T, Grande E +26 more
Plain English This study examined how two immunotherapy treatments, pembrolizumab and avelumab, affect survival in patients with advanced urothelial carcinoma, especially those with liver metastases. They found that patients receiving pembrolizumab had an average survival of 17.5 months while those on avelumab lived for about 25.8 months. Notably, patients without liver metastases lived significantly longer than those with liver involvement, with survival times of 27 months versus 16.4 months, respectively; and factors like a higher body mass index or better performance status were linked to longer survival times.
Who this helps: This research helps patients with advanced urothelial carcinoma by highlighting the benefits of immunotherapy treatments.
Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis.
2026
Cancer metastasis reviews
Vitale E, Maistrello L, Ciccimarra F, Rizzo A, Soares A +7 more
Plain English This study looked at the occurrence of low sodium levels (hyponatremia) in cancer patients who are treated with immune checkpoint inhibitors (ICIs). They found that about 5% of these patients experienced any level of hyponatremia, while 1.2% had mild cases and about 5.5% experienced severe cases. These findings are important because they emphasize the need for regular monitoring of electrolyte levels in patients receiving ICIs to ensure safer and better treatment outcomes.
Who this helps: This helps patients undergoing cancer treatment with immune checkpoint inhibitors.
Impact of heat stress on the miRNA cargo of pre-ovulatory follicular fluid extracellular vesicles and fertility in dairy cattle.
2026
Theriogenology
Kosior MA, Masiello L, Piscopo F, Esposito R, Rizzo A +6 more
Plain English This study looked at how heat stress affects fertility in dairy cows by examining changes in tiny particles called extracellular vesicles (EVs) found in fluid around their eggs. When temperatures were high during summer, the cows had a lower conception rate of 24.4% compared to 39.9% in the cooler winter months, alongside significant changes in the types of molecules (miRNAs) present in the EVs. These changes likely impact how the ovaries function, helping to explain why cows are less fertile when it’s hot.
Who this helps: This research benefits dairy farmers and veterinarians by highlighting the impact of heat on cow fertility.
Artificial intelligence in cancer screening: a narrative review of current evidence and future directions.
2026
Expert review of molecular diagnostics
Yazarkan Y, Sonmez G, Sahin TK, Rizzo A, Guven DC
Plain English This study looked at how artificial intelligence (AI) can be used to improve cancer screening methods, which are crucial for detecting the disease early when it's most treatable. The authors found that AI can make screenings more accurate and efficient, helping to identify people at risk more effectively. However, there are still challenges to address, such as ensuring fairness in how well AI works for different groups and avoiding unnecessary diagnoses.
Who this helps: This benefits patients by potentially leading to earlier cancer detection and better treatment outcomes.
Efficacy and safety of immune-based combinations in metastatic hepatocellular carcinoma: a systematic review and network meta-analysis.
2026
BMC cancer
de Moura ACC, Rizzo A, Santos TAB, Olivato GB, Monteiro FSM
Plain English This study looked at new treatment combinations that use immune checkpoint inhibitors (ICIs) for patients with advanced liver cancer, comparing their effectiveness and safety to older treatments called tyrosine kinase inhibitors (TKIs). Researchers analyzed data from six clinical trials involving nearly 4,000 patients and found that ICI combinations improved overall survival rates by 28% and response rates by 213%, without significantly increasing serious side effects. This is important because these new treatments provide better outcomes for patients while maintaining an acceptable safety profile.
Who this helps: This helps patients with metastatic liver cancer seeking more effective treatment options.
Preliminary report on advanced biliary cancer patients receiving multimodality treatment in the immunotherapy era: a real-world multicentre experience.
2026
Therapeutic advances in medical oncology
Salati M, Borghi E, Cuoghi Costantini R, Parisi A, Lancianese A +13 more
Plain English This study looked at patients with advanced biliary cancer, a type of cancer that is hard to treat, to see how they respond to a combination of therapies including chemotherapy and immunotherapy. Out of 241 patients treated, only 12 (4.9%) met the criteria for the study, with 91.6% of them still alive at the end of the study period, and 41.6% free of disease. The findings suggest that patients with fewer cancer spread (metastases) and a specific type of biliary cancer (intrahepatic cholangiocarcinoma) may benefit the most from more intense treatment strategies.
Who this helps: This helps patients with advanced biliary cancer by offering insights into potentially more effective treatment options.
Gene Expression Profile (GEP) Comparison of Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS).
2026
Cancers
Giubellino A, Cazzato G, Della Mura M, Broggi G, Rizzo A +4 more
Plain English This study looked at the genetic activity of two skin tumors: atypical fibroxanthoma (AFX), which is usually less aggressive, and pleomorphic dermal sarcoma (PDS), which is more aggressive. Researchers found that although both types of tumors have some similar genetic mutations, their gene-expression profiles are different, with specific pathways like the MAPK pathway and others playing a role in distinguishing them. This is important because identifying these differences can help doctors diagnose and treat these tumors more effectively.
Who this helps: This helps doctors and patients dealing with skin tumors.
Implant Surface Characteristics and Peri-Implant Outcomes: A Systematic Review of Clinical and Microbiological Evidence.
2026
Bioengineering (Basel, Switzerland)
Dipalma G, Marinelli G, Bassi P, Lagioia R, Rizzo A +5 more
Plain English This research examined how different surface features of dental implants affect their success and the health of surrounding tissues. The review looked at 13 studies and found that the type of implant surface had little impact on long-term bone loss or tissue health; most differences were only seen during the early healing stage or in patients with weaker bone. This highlights that ongoing health around implants depends more on factors like the patient's overall health and bacterial presence rather than just the implant's surface design.
Who this helps: This benefits patients receiving dental implants and the dental professionals treating them.
Nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil for metastatic pancreatic ductal adenocarcinoma following gemcitabine-based therapy. A systematic review and meta-analysis of randomized controlled trials.
2026
Clinical & experimental metastasis
Vitale E, Rizzo A, Maistrello L, Sciacovelli AM, De Luca R +7 more
Use of Pentoxifylline to Improve Seminal Parameters in Dogs.
2026
Veterinary medicine and science
Cicirelli V, Burgio M, Frattina L, Caprio F, Robbe D +2 more
Plain English This study looked at how a medication called pentoxifylline affects semen quality in dogs with different sperm concentrations. After giving 10 mg/kg of pentoxifylline to 29 dogs, researchers found a significant increase in sperm concentration and movement, particularly in dogs with low sperm counts. This is important because it shows pentoxifylline might help improve fertility in male dogs that struggle to produce healthy semen.
Who this helps: This helps dog owners and veterinarians addressing fertility issues in male dogs.
Mendelian Randomization Studies of Major Depressive Disorder, Schizophrenia, Bipolar Disorder, and Cancers. A PRISMA Review and Meta-Analysis.
2026
Endocrine, metabolic & immune disorders drug targets
Vitale E, Maistrello L, Rizzo A, Santoni M, Motamed-Jahromi M +2 more
Plain English This study looked at whether severe mental health disorders like schizophrenia, bipolar disorder, and major depression increase the risk of developing cancer. They analyzed data from seven previous studies and found a small but significant link, specifically noting that people with schizophrenia had a 5% higher chance of developing cancer. Understanding these connections is important because it may lead to better health management strategies for individuals with these mental health disorders.
Who this helps: This helps patients with severe mental health disorders and healthcare providers who treat them.
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.
2026
European urology open science
Mandel P, Wenzel M, Chun F, Graefen M, Gandur Quiroga MN +29 more
Plain English This study looked at how local treatment (LT) to the prostate affects patients who have recently been diagnosed with low-volume metastatic hormone-sensitive prostate cancer and are receiving androgen receptor pathway inhibitors (ARPI). The researchers found that 18% of the 454 patients received LT, and those who did had a longer average overall survival—about 4.67 months more—compared to those who only received ARPI. This matters because improving survival times can significantly impact the quality of life for these patients.
Who this helps: Patients with low-volume metastatic hormone-sensitive prostate cancer.
Artificial Intelligence in Spine Imaging Interpretation.
2026
Seminars in musculoskeletal radiology
Gitto S, Omoumi P, Albano D, Xiberta P, Rossi S +5 more
Plain English This study looks at how artificial intelligence (AI) can improve the way doctors interpret images of the spine, which is important because spinal disorders are a major cause of disability. The researchers reviewed various AI methods and found that they can enhance the accuracy of diagnoses and make the workflow for doctors more efficient. This matters because better imaging interpretation can lead to timely and effective treatment for patients with conditions like fractures, deformities, and tumors.
Who this helps: This helps doctors, particularly radiologists, and ultimately benefits patients with spinal disorders.
Multigene assays in early breast cancer: Current evidence, limits and future directions.
2026
Cancer treatment reviews
Fina E, Lauro VD, Rizzo A, Bove S, Comes MC +2 more
Plain English This research paper looks at how new tests called multigene assays can help doctors understand and treat early breast cancer better. The study highlights that tools like Oncotype DX, MammaPrint, and others provide valuable information that allows for more personalized treatment plans, improving patient care. As these tests continue to evolve, they are expected to make a significant impact on how breast cancer is managed.
Who this helps: This helps patients with early-stage breast cancer and their doctors.
Plain English This study looked at new types of PET imaging that could be better than the current method, [F]FDG, for examining inflammation and infection in the body. Researchers found that new PET tracers could give more detailed information about different inflammatory processes, which might help in diagnosing conditions like vasculitis or inflammatory bowel disease. For instance, new agents like fibroblast activation protein inhibitors showed promise in improving the understanding of inflammation, although more research is necessary before they can be widely used.
Who this helps: This helps patients with inflammatory diseases and their doctors by providing better diagnostic tools.
Predictive and prognostic factors for immunotherapy response in head and neck squamous cell carcinoma: a narrative review.
2026
Expert review of clinical pharmacology
Calabrò C, De Palma G, Gheit T, Iacovelli S, Mastrandrea G +2 more
Plain English This study looked at how certain factors affect the response to new immunotherapy treatments in patients with head and neck cancer. Researchers found that PD-L1 expression is the only well-validated indicator of treatment success, but factors like HPV status, tumor mutation rates, and a patient’s overall health also play significant roles. Understanding these variables is crucial because it can help doctors tailor treatments to achieve better outcomes for patients.
Who this helps: This helps patients with head and neck cancer and their doctors.
Detection rate of [Tc]Tc-PSMA SPECT/CT in prostate cancer: a systematic review and a meta-analysis.
2026
Frontiers in medicine
Albano D, Tasevski S, Sadeghi R, Treglia G, Rizzo A
Plain English This study looked at a new imaging method called [Tc]Tc-PSMA SPECT/CT for diagnosing prostate cancer. The findings showed that it accurately detected prostate cancer in about 79.7% of cases during initial diagnosis and 75.4% during follow-up for recurring cancer. This is important because it offers a more affordable and accessible option for diagnosing prostate cancer, especially in areas where more expensive imaging techniques are not available.
Who this helps: This helps patients, especially in underserved regions, and doctors who need effective diagnostic tools.
Correction: Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative review.
2026
Frontiers in public health
Scaglione G, Mastroianni N, Rizzo A, Palomba E, Carcione D +6 more
Plain English This paper looks at how using artificial intelligence alongside genome sequencing can help fight antibiotic resistance, which is when bacteria no longer respond to medicines that used to kill them. The study found that integrating these technologies can improve the speed and accuracy of identifying resistant bacteria, which is crucial for treating infections effectively. This matters because antibiotic resistance is a growing problem that affects the health of many people worldwide.
Who this helps: Patients with infections resistant to standard treatments.
Enfortumab vedotin in ECOG-PS 2 advanced urothelial carcinoma patients: a real-world study from the ARON-2project.
2026
BMC cancer
Rizzo A, Ciccimarra F, de Casio Zequi S, Bove S, Comes MC +21 more
Plain English This study examined how well the cancer treatment enfortumab vedotin (EV) works for patients with advanced urothelial carcinoma (a type of bladder cancer) who have a performance status of ECOG-PS 2, which indicates they are more affected by their illness, compared to those with ECOG-PS 0 or 1. Researchers found that patients with ECOG-PS 2 had a median overall survival of 6.34 months and a progression-free survival of 3.98 months, significantly shorter than the 13.63 months and 7.39 months for patients with ECOG-PS 0-1. These results matter because they highlight that patients in poorer health may have worse outcomes with this treatment, underscoring the need for more research to understand how to best help them.
Who this helps: This research benefits patients with advanced urothelial carcinoma and their healthcare providers by providing insights on treatment outcomes based on their health status.
An agent-based learning model integrating sex differences in renal cell carcinoma.
2026
Frontiers in immunology
Merelli E, Taha T, Caputo M, Obude D, Papa E +7 more
Plain English This study looked at how sex differences affect the progression and treatment of renal cell carcinoma (RCC), a type of kidney cancer. Researchers created a computer model that combines information about hormones, the immune system, and tumor genetics to see how these factors interact in both men and women. They found that women typically had slower initial responses to treatment but showed stronger immune reactions later, leading to faster tumor shrinking, while men had steadier early responses but tumors that were better at adapting and resisting treatment.
Who this helps: This research benefits patients with renal cell carcinoma by providing insights that could lead to more personalized treatment strategies.
Maggio MG, Luca A, Cicero CE, D'Agate C, Bonanno L +5 more
Plain English This study looked at how people with essential tremor (ET) experience empathy and emotional awareness (called alexithymia) compared to healthy individuals. Researchers found that while ET patients scored lower in global cognitive ability, their self-reported empathy and emotional awareness were similar to those of healthy controls, indicating that their social and emotional skills are mostly intact despite cognitive differences. This matters because it suggests that people with essential tremor can maintain their emotional capacities, which can influence how they interact socially.
Who this helps: Patients with essential tremor and their families.
Liquid biopsy for biliary tract cancer: available evidence and future research directions.
2026
Expert review of molecular diagnostics
Erul E, Ricci AD, Della Mura M, Cazzato G, Massafra R +3 more
Plain English This study examines how liquid biopsies, particularly tests that analyze tumor DNA found in blood, can help in diagnosing and monitoring biliary tract cancers (BTCs). Researchers found that these blood tests can detect genetic changes in tumors and monitor how patients respond to treatments, potentially improving patient care when tissue samples are unavailable or insufficient. The findings suggest that using this method alongside traditional tissue tests can enhance treatment decisions and tracking disease progression, though more standardization and research are needed.
Who this helps: This helps patients with biliary tract cancer and their doctors in making better treatment choices.
Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1).
2026
Frontiers in immunology
Beas-Lozano EL, Scagliarini S, Valdez-Sandoval PI, Esparza-Orozco MF, Bilen MA +20 more
Plain English This study examined the occurrence of severe side effects (grades 3-4) in patients with advanced kidney cancer who were treated with immune combination therapies. Out of 2,401 patients studied, 34% experienced these serious side effects, with the combination of pembrolizumab and lenvatinib having the highest rate of severe effects. Importantly, this research shows that the rate of severe side effects in clinical practice is lower than what's usually reported in controlled trials, indicating that real-world treatments may have different outcomes.
Who this helps: Patients and doctors making treatment decisions for advanced kidney cancer.
Cellular Dermatofibroma Harboring a Novel MYADM::PRKCG Gene Fusion: A Case Report.
2026
The American Journal of dermatopathology
Della Mura M, Krimchansky O, Rizzo A, Trilli I, Salzillo C +5 more
Plain English This study focused on a skin tumor called dermatofibroma, looking at a specific case where a 56-year-old man had a unique genetic change. Researchers found a new gene fusion, MYADM::PRKCG, that allows for better classification of this type of tumor. Understanding these genetic changes is important because it helps doctors diagnose and treat patients more accurately.
Who this helps: This helps patients with rare skin tumors and their doctors.
Pregnancy diagnosis based on pregnancy-associated glycoproteins detection in dairy cow milk: Factors influencing measurement.
2026
Veterinary and animal science
Bramante G, Forte L, Andriulo OM, Carbonari A, Maggiolino A +5 more
Plain English This study looked at how well a test that measures pregnancy-related proteins in the milk of dairy cows can determine if they are pregnant. Researchers examined data from 2,460 cows and found that milk protein levels were higher in cows that had been pregnant before and increased the further along they were in their pregnancy. Notably, 12% of cows marked as pregnant did not give birth later, highlighting the importance of confirming pregnancy with additional checks.
Who this helps: This helps dairy farmers and veterinarians improve pregnancy diagnosis in cows, leading to better herd management.
Prognostic value of interim post-treatment SPECT/CT following lutetium-177 (177Lu)-PSMA therapy in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
2026
Frontiers in medicine
Shamshirgaran A, Samadi MH, Aboutalebi F, Zahedian S, Sahafi P +6 more
Plain English This study looked at how an imaging technique called post-treatment SPECT/CT can help predict survival outcomes in patients with advanced prostate cancer who received a specific type of therapy. Researchers found that if new cancer lesions appeared, patients faced a significantly higher risk of death (about 2.78 times higher) and had shorter periods without worsening prostate-specific antigen (PSA) levels (4.72 times higher risk). Additionally, increases in the total tumor volume also indicated worse survival outcomes.
Who this helps: This helps patients with metastatic castration-resistant prostate cancer and their doctors in understanding their treatment responses better.
Vertical greening systems and green roofs for greywater treatment and reuse: experiment-based recommendations for research and practice.
2026
Journal of environmental management
Rizzo A, Sarti C, Masi F, Costamagna E, Boano F +1 more
Plain English This study looked at how green roofs and vertical gardens can use greywater, which is wastewater from sinks and showers, to help cities manage water better during dry spells. The researchers found specific design tips for these systems, like the best soil depth and slope for roofs, to effectively treat greywater and reuse it for purposes that don’t require clean drinking water. This is important because it helps conserve drinking water and supports sustainable urban living.
Who this helps: This benefits city planners, environmentalists, and residents looking for sustainable water solutions.
Malignant uterine PEComa: a narrative literature review and challenging case report.
2026
Journal of cancer research and clinical oncology
Maiorano MFP, Sorino J, Della Mura M, Di Nanni D, Cazzato G +5 more
Plain English This study looked at a rare type of uterine cancer called malignant PEComa, which was diagnosed in a 44-year-old woman after her symptoms, like abnormal bleeding and pelvic pain, were mistaken for a common fibroid. The diagnosis was confirmed through surgery, revealing aggressive cancer characteristics, but two years later, the patient is cancer-free without any additional treatments. This research highlights the importance of careful evaluation and surgery for this cancer type, and it suggests that targeted drug therapies might help those with more serious cases.
Who this helps: This benefits patients with malignant uterine PEComa and their healthcare providers.
D-dimer as a marker of severe disease in imported malaria: a retrospective observational study.
2026
Travel medicine and infectious disease
Poloni A, Rizzo A, Giacomelli A, Colaneri M, Arrigo C +6 more
Plain English This study examined the D-dimer levels in patients with a type of severe malaria called Plasmodium falciparum malaria, to see if D-dimer can help predict how serious the disease is. Out of 85 patients studied, 21 were classified as having severe malaria, and those patients had much higher D-dimer levels (an average of about 10,943 µg/L) compared to those with milder cases (about 2,245 µg/L). The study found that higher D-dimer levels are linked to more severe disease, which could help doctors identify and treat severe malaria more effectively.
Who this helps: This helps doctors in diagnosing and managing severe malaria in patients.
The Psychological and Behavioural Correlates of Workplace Victimization.
2026
Brain sciences
Rizzo A, Maggio MG, Barbera M, Bruno F, Giorgi G +7 more
Plain English This study looked at how repeated psychological abuse at work affects people's mental health. Researchers found that workers showed high levels of depression, anxiety, and anger, with many experiencing physical symptoms like fatigue and suspiciousness. For example, anxiety levels were notably high, with 65.06 points recorded, compared to a typical score. This matters because it highlights the significant emotional and psychological distress that workplace victimization can cause, which can impact overall well-being and job performance.
Who this helps: This benefits workers who experience bullying or harassment in their jobs.
Improving Inter-Rater Reliability in Radiographic Edema Scoring in Acute Respiratory Failure Through Structured Training and Expert Feedback.
2026
ATS scholar
Qurashi H, Jain P, Joyce R, Singh N, Inman K +22 more
Plain English This study focused on improving how consistently doctors score lung swelling using chest X-rays in critically ill patients. Researchers trained 16 doctors with a structured program and expert feedback, resulting in a significant improvement in scoring reliability, where inter-rater reliability increased from 0.89 to 0.93 after training. This matters because better scoring can lead to more accurate assessments and treatment for patients with acute respiratory failure.
Who this helps: This helps doctors, especially those interpreting chest X-rays for critical care patients.
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.
2026
Neurology
Foschi M, De Santis F, Gabriele F, Ornello R, D'Anna L +95 more
Plain English This study looked at patients with atrial fibrillation who suffered a stroke even while taking blood-thinning medications. Among 1,649 patients studied, about 24% had additional causes for their strokes, mainly related to artery blockages, and these patients faced a higher risk of having another stroke (6.0% vs. 2.7%), greater disability, and increased death rates. This research highlights the importance of tailoring treatment strategies for patients at higher risk of complications after having a stroke while on anticoagulants.
Who this helps: Patients with atrial fibrillation and healthcare providers managing their care.
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.
2026
Nature communications
Fernando W, Clucas J, Rizzo A, Singer R, Goode E +40 more
Plain English This study looked at how a specific type of cell death, called necroptosis, affects the success of a cancer treatment that combines immunotherapy and chemotherapy, particularly for advanced triple-negative breast cancer (TNBC). Researchers found that when this cell death occurs both in tumor cells and in the surrounding tissue, it helps the treatment work better. They showed that when certain genes were deleted, the treatment was much less effective, highlighting the importance of the tumor environment in making therapies work.
Who this helps: This helps patients with triple-negative breast cancer and doctors looking for more effective treatment options.
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.
2026
European stroke journal
Foschi M, De Santis F, Gabriele F, D'Anna L, Zini A +94 more
Plain English This study looked at how having cancer affects the recovery of patients who experienced a stroke while taking blood thinners for atrial fibrillation. Among nearly 1,650 patients, those with cancer had a much higher risk of having another stroke (8.2% vs. 2.8%) and poorer recovery outcomes after 90 days. Specifically, patients with active cancer had more than four times the risk of a new stroke and a nearly threefold higher chance of serious bleeding.
Who this helps: This information benefits patients with cancer and their doctors by highlighting the need for closer monitoring and tailored treatment plans after a stroke.
Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project.
2025
Pathologica
Cerbelli B, Marletta S, Amato M, Campora M, Costarelli L +18 more
Plain English This study focused on improving how doctors assess HER2-(ultra)low breast cancer, a type of cancer that has a low level of HER2 protein. Researchers found that while there was a 69% agreement with expert assessments overall, this dropped to only 48% when looking at especially difficult cases. This is important because better classification can lead to more effective treatments for patients with this kind of cancer.
Who this helps: Patients with HER2-(ultra)low breast cancer.
testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needs.
2025
Pathologica
Mane E, Cursano G, Venetis K, Frascarelli C, Pepe F +21 more
Plain English This study looked at how well Italian healthcare institutions can conduct a specific genetic test (PIK3CA) that guides treatment for hormone receptor-positive, HER2-negative metastatic breast cancer. The research involved responses from 118 healthcare professionals, revealing that 88% of institutions can perform this test, but nearly half lack formal accreditation. The findings show progress in the availability of testing but also highlight significant issues, such as inconsistent testing practices and limited use of newer testing methods, which are important for ensuring all patients receive effective care.
Who this helps: Patients with hormone receptor-positive, HER2-negative metastatic breast cancer.
Matteo Santoni Mario Della Mura Gerardo Cazzato Fernando Sabino Marques Monteiro Francesco Massari Andrey Soares Angela Dalia Ricci Raffaella Massafra Marta Colaneri Giorgio Treglia
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.